TRANSFORMATIONAL MEDICINES THAT MAKE A DIFFERENCE
DEAD

Serial Number

88402237

Owner

THERAVANCE BIOPHARMA R&D IP, LLC

Attorney

Beth H. Alter

Filing Date

Apr 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TRANSFORMATIONAL MEDICINES THAT MAKE A DIFFERENCE Trademark

Serial Number: 88402237

TRANSFORMATIONAL MEDICINES THAT MAKE A DIFFERENCE is a trademark filed by THERAVANCE BIOPHARMA R&D IP, LLC on April 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

THERAVANCE BIOPHARMA R&D IP, LLC (14 trademarks)

901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080

Entity Type: 16

Trademark Details

Filing Date

April 25, 2019

Registration Date

Not Registered

Published for Opposition

March 10, 2020

Goods & Services

Pharmaceuticals, namely, medical and veterinary pharmaceutical preparations for the treatment of human and animal diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use; diagnostic preparations and materials, namely, diagnostic agents, preparations and substances for medical, pharmaceutical and veterinary purposes; disinfectants and antiseptics; medical dressings, coverings and applicators, namely, bandages for dressings, gauze for dressings, dressings for wounds, burns and surgery, cotton and synthetic swabs for medical use, adhesive plasters for medical use, inhalers filled with pharmaceutical products for the treatment of respiratory diseases and disorders; natural remedies, namely, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances and sleep disorders, and for the treatment of human diseases and disorders of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; natural dietary supplements for the treatment of human diseases and disorders of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical products for treatment of human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely, anti-infectives

Scientific and technological services, namely, scientific research, analysis, design and testing, in the field of pharmaceuticals and medicine; medical and pharmacological research services in the field of pharmaceuticals and medicine; natural science services, namely, scientific research, analysis, design and testing in the field of natural medicine and natural remedies; testing, namely, testing of pharmaceuticals and providing medical testing services in the field of research into human diseases of the respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; authentication, namely, authentication of pharmaceutical and medicines; quality control for others; scientific investigation for medical purposes; bacteriological, chemical and biological investigation being scientific investigation for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 5, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 5, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2022 EXRA
SOU EXTENSION 5 GRANTED
Nov 10, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 10, 2022 AITU
SOU EXTENSION 5 FILED
Nov 3, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 3, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2022 EXRA
SOU EXTENSION 4 GRANTED
Apr 28, 2022 EX4G
SOU EXTENSION 4 FILED
Apr 28, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2021 EXRA
SOU EXTENSION 3 GRANTED
Oct 7, 2021 EX3G
SOU EXTENSION 3 FILED
Oct 7, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 7, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2021 EXRA
SOU EXTENSION 2 GRANTED
Apr 29, 2021 EX2G
SOU EXTENSION 2 FILED
Apr 29, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 29, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 23, 2020 EXRA
SOU EXTENSION 1 GRANTED
Sep 21, 2020 EX1G
SOU EXTENSION 1 FILED
Sep 21, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 21, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2020 TROA
NON-FINAL ACTION MAILED
Jul 22, 2019 CNRT
NON-FINAL ACTION WRITTEN
Jul 10, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 8, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2019 NWOS
NEW APPLICATION ENTERED
Apr 29, 2019 NWAP